Articles Meeting the needs of cancer patients and healthcare provider... Complex and evolving cancer treatment pathways require comprehensive and tailored support programmes.
Views & Analysis Immunotherapies in oncology: the future of cancer treatment ... Partnerships, co-marketing and the positioning of drugs are shaping the competitive landscape in oncology.
Views & Analysis Taking up the gauntlet A review of Cancer Research UK's Grand Challenge awards programme for the latest cancer research projects.
News AZ highlights data from next-gen oncology drugs at ASCO Tesara and Takeda among other companies to publish data.
Views & Analysis ASCO 2017: Breast cancer next target for Keytruda Immunotherapy combinations will be the focus - but attention is shifting towards these agents proving their overall survival benefits.
Views & Analysis The cancer challenge: the quest for a cure is only half the ... The cancer challenge is affecting more and more people worldwide, with 21 million cases expected by 2030.
News FDA starts review of Regeneron's drug for rare disease FOP Can Regeneron's drug for ultra-rare bone disease FOP pick up the baton from Ipsen's Sohonos, whose growth has stalled?
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
